Methods for treating glycogen storage disease type IV usng lysosomal acid alpha-glucosidase
US9850474B2 · kind B2 · utility
3Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 30, 2015 |
| Grant date | Dec 26, 2017 |
| Priority date | — |
| Expiry date | Jun 9, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y302/0102
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure relates, in general, to Glycogen Storage Disease and, in particular, to a method of treating Glycogen Storage Disease and to compounds and compositions suitable for use in such a method.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.